The place of thalidomide in the treatment of multiple myeloma
Thalidomide represents the first attempt in multiple myeloma (MM) patients to overcome resistance to chemotherapy through a biological agent. The exciting results reported in the first study by Singhal et al. in 1999 [1] led to several other studies which aimed to evaluate its efficacy in different...
Сохранить в:
| Главные авторы: | , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Frontiers Media S.A.
2011-12-01
|
| Серии: | Oncology Reviews |
| Предметы: | |
| Online-ссылка: | http://oncologyreviews.org/index.php/or/article/view/157 |
| Метки: |
Нет меток, Требуется 1-ая метка записи!
|